ArticleBMC gastroenterology2025

Efficacy and safety of reduced thromboprophylaxis with low molecular weight heparin for hepatocellular carcinoma after conversion therapy.

Xu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.